Sarepta (SRPT): Accelerated Approval Seen Pending Dystrophin Data Analysis - Oppenheimer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/1/2026

1. SPY
2. AVAV
3. NVDA
4. NKE
5. MU
6. DLR
7. EOSE
8. AAPL
9. TSLA
10. VSH

Go back to Sarepta (SRPT): Accelerated Approval Seen Pending Dystrophin Data Analysis - Oppenheimer
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.97 +0.95 (5.58%)
Previous Close $17.02    52 Week High $63.73 
Open $17.50    52 Week Low $8.00 
Day High $18.19    P/E N/A 
Day Low $16.90    EPS $-5.69 
Volume 4,213,972